By down-regulation of theantiapototic factor Bcl-2, the cancer cells undergo apoptosis andincrease their sensitivity to DOX-mediated cell death.148 Nanoparticles are valuable for targeted deliveryand enhanced cellular uptake of siRNA–Bcl-2 and DOX in anticancertherapy.149. Here, BCL2 is linked to cancer.